"PEPTIDES ACTING AS BOTH GLP-1 RECEPTOR AGONISTS AND GLUCAGON RECEPTOR ANTAGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE"

Application 774/DELNP/2004 published 2007-01-12, filed 2004-03-25
The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.

Applicant

1)BAYER PHARMACEUTICALS CORPORATION
:400 MORGAN LANE, WEST HAVEN, CONNECTICUT 06516, UNITED STATES OF AMERICA. U.S.A.

Inventor

1)CLARK PAN 2)JAMES WHELAN 3)KEVIN B. CLAIRMONT

International Info

Classification: C07K 16/00
Publication Number: WO 03/040309
Application Date: 2002-10-04

Priority Information

60/327,730 U.S.A. 2001-10-05